免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

臨床試驗

Compassionate Access of the Miltenyi Device for CD34+ Cell Selection

NCT:NCT02438904 · RECRUITING

NCT IDNCT02438904
狀態RECRUITING
開始日期2015-05-06
完成時間2027-05-01
SponsorM.D. Anderson Cancer Center (OTHER)
First posted
Last updated

簡要摘要

Objectives: Primary Objective To provide compassionate access to the Miltenyi device for CD34+ cell infusions to patients who experience poor graft function after stem cell transplantation (SCT).

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。

↑